+ Phase-I-support-Safety-pharmacology

Safety pharmacology

We work closely with our expert partner CERB to assess primary and secondary functions, including standard core-battery assessments and specialised, non-standard pharmacology.

Introduction

We routinely manage safety pharmacology studies, generally as part of “first-in-man” non-clinical programmes.  These studies are not conducted in-house but are sub-contracted to a partner organisation with specialist experience in this area.  Our preferred partner is CERB.

CERB has more than 100 models/methods established for the assessment of primary and secondary functions or safety of new drug candidates. http://www.cerb.fr/index.html

  • Primary pharmacology
  • Proof of concept
  • Disease models
  • Early safety pharmacology
  • ICH S7A Core battery

Our News & Events
MDC Connects Webinar 8: Is my Compound Safe?
1 June 2020
Join Sequani for the how to get your molecule in to humans webinar
Read More
Mice in Juvenile Toxicity Testing
26 November 2018
Mice in Juvenile Toxicity Testing
Read More
Biomarker Validation – Mountain, Molehill or Something in Between?
13 June 2018
Biomarker Validation – Mountain, Molehill or Something in Between?
Read More